MaxCyte, Inc.
MXCT
$2.15
-$0.05-2.27%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.26M | -10.60M | -11.56M | -9.38M | -9.53M |
| Total Depreciation and Amortization | 1.28M | 1.53M | 1.07M | 1.08M | 1.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.27M | 2.96M | 2.92M | 2.25M | 1.17M |
| Change in Net Operating Assets | -7.69M | -1.71M | 3.19M | 1.21M | -3.44M |
| Cash from Operations | -14.41M | -7.82M | -4.39M | -4.83M | -10.56M |
| Capital Expenditure | -653.00K | -147.00K | -406.00K | -294.00K | -804.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1.77M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.96M | -1.52M | 4.01M | 19.68M | -13.59M |
| Cash from Investing | 9.53M | -1.67M | 3.61M | 19.39M | -14.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 383.00K | 412.00K | 228.00K | 713.00K | 703.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 383.00K | 412.00K | 228.00K | 713.00K | 703.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.50M | -9.07M | -555.00K | 15.26M | -24.26M |